New CMO For Sanifit
Spanish biopharma company Laboratoris Sanifit S.L. has appointed Dr Preston S. Klassen chief medical officer and president of its new US subsidiary, Sanifit Inc. Klassen joins the business from Orexigen Therapeutics, where he headed the global development team as executive vice president. He previously held various positions at Amgen Inc., including therapeutic area head for nephrology, prior to which he was a faculty member at Duke University’s division of nephrology for five years.
You may also be interested in...
Diffusion Pharmaceuticals and WPD Pharmaceuticals get new chief medical officers.
The UK backs the world's first COVID-19 human challenge studies to accelerate research – though the first results will not be ready until mid-2021.
New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.